Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin 1 and Vincristine in Relapsed/Progressive NHL
NCT00058305Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2003
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in non-Hodgkin lymphoma (NHL), sponsored by National Cancer Institute. Started Mar 2003; status: completed.
02
Drugs
bryostatin-1
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00058305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058305.